Search hospitals
>
Missouri
>
Saint Louis
Siteman Cancer Center at Christian Hospital
Claim this profile
Saint Louis, Missouri 63110
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Pancreatic Cancer
Conducts research for Lymphoma
491 reported clinical trials
69 medical researchers
Summary
Siteman Cancer Center at Christian Hospital is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Pancreatic Cancer, Lymphoma and other specialties. Siteman Cancer Center at Christian Hospital is involved with conducting 491 clinical trials across 609 conditions. There are 69 research doctors associated with this hospital, such as Robert J. Hayashi, Brian A Van Tine, M.D., Ph.D., Douglas R. Adkins, and Premal H Thaker, M.D., M.S..
Area of expertise
Lung Cancer
Siteman Cancer Center at Christian Hospital has run 103 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Siteman Cancer Center at Christian Hospital has run 91 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Robert J. Hayashi
Washington University School of Medicine
8 years of reported clinical research
Brian A Van Tine, M.D., Ph.D.
Washington University School of Medicine
4 years of reported clinical research
Douglas R. Adkins
Washington University School of Medicine
7 years of reported clinical research
Premal H Thaker, M.D., M.S.
Washington University School of Medicine
3 years of reported clinical research
Clinical Trials running at Siteman Cancer Center at Christian Hospital
Lung Cancer
Breast Cancer
Prostate Cancer
Skin Cancer
Breast cancer
Cancer
Small Cell Lung Cancer
Esophageal cancer
Brain Tumor
Esophageal Adenocarcinoma
Radiotherapy
for Lung Cancer
This study is being done to answer the following question: Can the chance of lung cancer growing or spreading be lowered by adding targeted radiotherapy to the usual combination of drugs? This study is being done to find out if this approach is better or worse than the usual approach for lung cancer. The usual approach is defined as the care most people get for non-small cell lung cancer.
Recruiting
2 awards
Phase 3
4 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting
2 awards
Phase 3
12 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting
2 awards
Phase 3
4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Siteman Cancer Center at Christian Hospital?
Siteman Cancer Center at Christian Hospital is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Pancreatic Cancer, Lymphoma and other specialties. Siteman Cancer Center at Christian Hospital is involved with conducting 491 clinical trials across 609 conditions. There are 69 research doctors associated with this hospital, such as Robert J. Hayashi, Brian A Van Tine, M.D., Ph.D., Douglas R. Adkins, and Premal H Thaker, M.D., M.S..
Where is Siteman Cancer Center at Christian Hospital located?
The Siteman Cancer Center at Christian Hospital is situated at 11133 Dunn Rd, St. Louis, MO 63136. This center is a key part of the Siteman Cancer Center network, which also encompasses facilities at the Washington University Medical Campus, West County, North County, and Barnes-Jewish Hospital.
Who should I call to ask about financial aid or insurance network?
**Siteman Cancer Center at Christian Hospital - Financial and Insurance Information** - For financial assistance, contact the Social Work Services and Financial Assistance department via the main Siteman Cancer Center contact information. They assist with insurance understanding and financial management of care. - Insurance inquiries can be directed to the Patient & Family Services section on the Siteman Cancer Center website, providing insights on insurance and patient care approach. - Visit the Payment Information page on the Siteman Cancer Center website for details on billing and financial assistance policies. - For billing and financial assistance questions, contact BJC HealthCare at (314) 747-8845 or toll-free (844) 747-8845. They offer support for financial assistance programs for uninsured or underinsured patients.
What insurance does Siteman Cancer Center at Christian Hospital accept?
The Siteman Cancer Center at Christian Hospital accepts various commercial healthcare plans, including Cigna, First Health/Coventry Health Care National Network, Humana, MultiPlan, and Private Health Care Systems (PHCS). Christian Hospital and Northwest HealthCare, members of BJC HealthCare, offer world-class medical care to North County, Greater St. Louis County, and Southern Illinois. For details on insurance plans accepted and the Blood and Marrow Transplant Program, visit the Siteman Cancer Center website.
What awards or recognition has Siteman Cancer Center at Christian Hospital received?
Siteman Cancer Center at Christian Hospital, situated in Saint Louis, Missouri, ranks as a premier U.S. cancer institution, holding the No. 10 spot among U.S. cancer centers. It is renowned for its extensive research programs and provides world-class care across a broad spectrum of cancer diagnoses. Specialized teams deliver innovative treatments at various locations, including the Siteman Cancer Center at Northwest HealthCare.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.